Results 191 to 200 of about 687,018 (362)

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

Journal of the American Medical Association (JAMA), 2017
Nicholas Downing, N. Shah, J. Aminawung, Alison M. Pease, J. Zeitoun, H. Krumholz, J. Ross   +6 more
semanticscholar   +1 more source

New Antimicrobial Agents Approved by the U.S. Food and Drug Administration in 1999 and New Indications for Previously Approved Agents

, 2000

openalex   +1 more source

Sam Greenhouse: his contributions as a consultant to the Food and Drug Administration [PDF]

, 2003
Robert T. O’Neill
openalex   +1 more source

Microbubble‐Controlled Delivery of Biofilm‐Targeting Nanoparticles to Treat MRSA Infection

Advanced Functional Materials, EarlyView.
Here, an effective strategy using microbubble (MB)‐controlled delivery of biofilm‐targeting nanoparticles (BTNs) for removal and therapy of methicillin‐resistant Staphylococcus aureus (MRSA) biofilm infections is introduced. In vivo delivery of MB with BTN is demonstrated to silence key bacterial genes involved in biofilm formation (icaA), bacterial ...
Ju Yeon Chung, Yujin Ahn, Joo Hun Lee, Seungju Yang, Seung Cheol Lee, Hyunjoon Kong, Hyun Jung Chung   +6 more
wiley   +1 more source

A Review of the Food and Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics. [PDF]

Perm J
Watson JR, Halpin L, Barroso V, Dahdouh G, Bursalyan J, Mohta S, Flores M, Gonzalez N, Gordineer J, Medina G, Oseguera C, Serrano JL.   +11 more
europepmc   +1 more source

Pediatric Drug Research: Food and Drug Administration Should More Efficiently Monitor Inclusion of Minority Children [PDF]

, 2003

openalex   +1 more source

Antibody‐Programmable Bimetallic Nanozymes for Transcriptional Blockade Therapy in HER2/ER‐Positive Breast Cancer

Advanced Functional Materials, EarlyView.
Zr‐Fe MOF@Ribociclib@Herceptin (ZFRH) efficiently targets/kills Human Epidermal Growth Factor Receptor 2/Estrogen Receptor‐positive (HER2/ER+) breast cancer cells. It combats tumors by: 1) Elevating ROS, altering redox balance; 2) Inhibiting transcription; 3) Inducing pyroptosis.
Hongkun Miao, Tong Ye, Mingjiang Liu, Jingchao Gao, Lian Tan, Qian Dong, Qingbo Lv, Qianqian Ye, Yu Wang   +8 more
wiley   +1 more source

US Food and Drug Administration Approval of Ciprofloxacin Hydrochloride for Management of Postexposure Inhalational Anthrax [PDF]

, 2004
Allen S. Meyerhoff, Renata Albrecht, Jonathan M. Meyer, Pierre-Alexandre Dionne, Karen M. Higgins, Dianne Murphy   +5 more
openalex   +1 more source

Engineering Topographical Cues to Enhance Neural Regeneration in Spinal Cord Injury: Overcoming Challenges and Advancing Therapies

Advanced Functional Materials, EarlyView.
Spinal cord injury (SCI) poses significant challenges for regeneration due to a series of secondary injury mechanisms. How to use biomaterial approach to target the failed regeneration after SCI remains a critical challenge. This review systematically evaluates current strategies to optimize biomaterial topographies for neurite outgrowth, axonal ...
Wei Xu, Fenghui Wang, Joshua Stein, Siqiao Wang, Pengfei Jiang, Letao Yang, Liming Cheng, Ki‐Bum Lee   +7 more
wiley   +1 more source

New Antimicrobial Agents Approvedby the U.S. Food and Drug Administration in 2003 and New Indicationsfor Previously ApprovedAgents [PDF]

, 2004

openalex   +1 more source